Skip to content
Menu

Arrowhead Pharma Q4 EPS $(3.01) Misses $(1.61) Estimate, Sales $37.794M Miss $55.838M Estimate

Benzinga Newsdesk 3 days ago

NewsEarningsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Arrowhead Pharma (NASDAQ:ARWR) reported quarterly losses of $(3.01) per share which missed the analyst consensus estimate of $(1.61) by 86.96 percent. This is a 1572.22 percent decrease over losses of $(0.18) per share

Arrowhead Pharma (NASDAQ:ARWR) reported quarterly losses of $(3.01) per share which missed the analyst consensus estimate of $(1.61) by 86.96 percent. This is a 1572.22 percent decrease over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $37.794 million which missed the analyst consensus estimate of $55.838 million by 32.32 percent. This is a 85.26 percent decrease over sales of $256.472 million the same period last year.

Read at benzinga.com